kd-496
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 13, 2022 (NCT05583201)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Claudin-18Immunity, passive
CLDN18 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06134960 | Phase 1 | Nov 16, 2023 | KAEDI, Peking University |
| NCT05583201 | Early Phase 1 (Phase 1) | Oct 13, 2022 | KAEDI, People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| KAEDI | Academic/Hospital | 2 | 0 | 1 | 2022 |
| Peking University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1